The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemoradiotherapy with ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial.
 
Johannes Laengle
Research Funding - Bristol-Myers Squibb
 
Irene Kuehrer
No Relationships to Disclose
 
Askin Kulu
No Relationships to Disclose
 
Julijan Kabiljo
No Relationships to Disclose
 
Daphni Ammon
No Relationships to Disclose
 
Rebecca Zirnbauer
No Relationships to Disclose
 
Anton Stift
No Relationships to Disclose
 
Friedrich Herbst
Consulting or Advisory Role - Afferent Pharmaceuticals
 
Bernhard Dauser
No Relationships to Disclose
 
Matthias Monschein
No Relationships to Disclose
 
Peter Razek
No Relationships to Disclose
 
Matthias Biebl
Consulting or Advisory Role - Afferent Pharmaceuticals
Research Funding - Ethicon/Johnson & Johnson
 
Hans Geinitz
No Relationships to Disclose
 
Wolfgang Hulla
No Relationships to Disclose
 
Leonhard Muellauer
No Relationships to Disclose
 
Joachim Widder
No Relationships to Disclose
 
Clemens Bittermann
Speakers' Bureau - Intuitive Surgical
Travel, Accommodations, Expenses - Intuitive Surgical
 
Friedrich Laengle
No Relationships to Disclose
 
Rainer Schmid
No Relationships to Disclose
 
Michael Bergmann
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb
 
On behalf of the CHINOREC Study Group
No Relationships to Disclose